Fig. 5. Biallelic TP53 abnormalities are either maintained or acquired at the time of progression of BL.

(A) Overview of clinical and molecular parameters for seven patients with matched samples taken at initial diagnosis (D) and at the time of progression (P). (B) One patient had matched samples from initial diagnosis and the time of reassessment.